Business
DarioHealth Corp. Announces Commencement of Public Offering of Common Stock
CAESAREA, Israel, May 21, 2019 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO) ("DarioHealth" or the "Company"), a global digital therapeutics innovator,
About this update from Dariohealth Corp.
[{"type":"text","content":"CAESAREA, Israel, May 21, 2019 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO) (\"DarioHealth\" or the \"Company\"), a global digital therapeutics innovator, today announced that it intends to offer and sell shares of common stock (or pre-funded warrants in lieu thereof) in an underwritten public offering. The proposed offering is subject to market and other conditions, as well as customary closing conditions, and there can be no assurance as to whether or when the proposed offering may be completed, or as to the actual size or terms of the offering.\n\n \nCraig-Hallum Capital Group is acting as sole managing underwriter for the offering. \nDarioHealth intends to use the net proceeds of the offering for commercialization efforts for its products, such as increased marketing or production expenses, and for general working capital purposes.\nThe securities are being offered pursuant to an effective shelf registration statement on Form S-3 (File No. 333-212644) that was previously filed with the Securities and Exchange Commission (the \"SEC\"), and was declared effective on August 3, 2016. The securities may be offered only by means of a prospectus. A preliminary prospectus supplement and accompanying prospectus relating to the offering will be filed with the SEC and will be available on the SEC's website at www.sec.gov. Copies of the preliminary prospectus supplement and accompanying prospectus related to the offering may also be obtained from Craig-Hallum Capital Group LLC at 222 South Ninth Street, Suite 350, Minneapolis, Minnesota 55402, Attention: Equity Capital Markets, by telephone at 612-334-6300, or by email at [email protected].\nThis press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or other jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or other jurisdiction.\nAbout DarioHealth Corp\nDarioHealth Corp. (Nasdaq: DRIO) is a leading global Digital Therapeutics (DTx) company revolutionizing the way people manage their health across the chronic condition spectrum. By delivering evidence-based interventions that are driven by data, high quality software and coaching, we developed a novel approach that empowers in...